ANNX Insider Trading Activity and SEC Form 4 Filings
ANNX insider trading summary
Over the past 12 months, insiders at Annexon, Inc. (ANNX) reported 13 open-market purchases worth $12.4M by 4 insiders and 10 sales worth $313K by 5 insiders on SEC Form 4. Net insider buying was $12.1M.
Latest ANNX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 24, 2026 | Douglas Love | President and CEO | Buy | $100K (26,065 @ $3.83) |
| May 28, 2026 | Muneer A Satter | Insider | Buy | $3.3M (613,497 @ $5.41) |
| May 11, 2026 | William H. Carson | Insider | Buy | $46K (8,000 @ $5.78) |
| Apr 10, 2026 | William H. Carson | Insider | Buy | $50K (8,000 @ $6.20) |
| Mar 10, 2026 | William H. Carson | Insider | Buy | $45K (8,000 @ $5.67) |
| Mar 2, 2026 | Jamie Dananberg | Chief Medical Officer | Sell | $32K (5,820 @ $5.43) |
| Mar 2, 2026 | Jennifer Lew | EVP & Chief Financial Officer | Sell | $30K (5,565 @ $5.42) |
| Mar 2, 2026 | Michael Overdorf | EVP & Chief Business Officer | Sell | $24K (4,339 @ $5.42) |
| Mar 2, 2026 | Dean Richard Artis | EVP & Chief Scientific Officer | Sell | $32K (5,894 @ $5.43) |
| Mar 2, 2026 | Ted Yednock | EVP & Chief Innovation Officer | Sell | $30K (5,566 @ $5.42) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.